Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Peginterferon Alfa-2b in Metastatic Melanoma
NCT00049530Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jan 2004
- Primary completion
- Aug 2012
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2b in melanoma, sponsored by Eastern Cooperative Oncology Group. Started Jan 2004; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00049530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049530.